SPL 2.11% 9.7¢ starpharma holdings limited

Biotech Daily editorial FYI, page-9

  1. 587 Posts.
    lightbulb Created with Sketch. 79
    I'm long on SPL but short term I have little faith that they can make anything from their recent COVID claims and in turn the share price will suffer. without backing up the claims the sell down could be pretty hard and may retest previous lows, we are already again sub $1.. would love to see different, but never in their history have they been able to get something to market on time and the market is now right to view their recent announcement with skepticism.

    such potential but it's hard holding when the short term outlook is bleak and the market so bearish. DEP doc trials were hopefully going to be released in first half, even they are now not likely until second half of this calendar year. Vivagel in the US won't happen this year. vivagel sales in short term seem to be slow / flat.

    Have been a massive supporter of SPL but in the current climate it sure is hard to hold.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.7¢
Change
0.002(2.11%)
Mkt cap ! $40.06M
Open High Low Value Volume
9.7¢ 9.7¢ 9.6¢ $12.35K 127.6K

Buyers (Bids)

No. Vol. Price($)
4 4036 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 5449 1
View Market Depth
Last trade - 15.55pm 09/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.